Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Haleon Share News (HLN)
HLN Share
Price
HLN Share
News
HLN Share
Chat
HLN Share
Trades12,954
HLN
Live RNS
HLN Share
Charts
HLN Level 2
Console
HLN Live
Share Price
HLN Broker
Ratings
HLN Directors
Deals
HLN Financial
Diary
HLN
Fundamentals
HLN Short
Positions1
HLN
Media
HLN Company
Research
HLN Company
Timeline1
Share Price Information for Haleon (HLN)
Last checked at -
Last checked at 
Intraday Haleon Share Chart
IN BRIEF: Haleon acquires remaining 12% stake in Chinese joint venture
Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Agrees to acquire the remaining 12% stake in Tianjin TSKF Pharmaceutical Co Ltd, its joint venture in China, following its acquisition of a further 33% interest in December 2024. The remaining stake will be bought from partner Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd for a total of CNY1.62 billion, around USD221 million. TSKF will become a wholly-owned subsidiary of Haleon.
The purchase will be funded via Haleon's existing cash resources and new local-currency debt and is expected to close within the next three months, it said.
Current stock price: 379.40 pence, up 0.1% in London on Tuesday morning
12-month change: up 17%
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Latest HLN News
- UK dividends calendar - next 7 days
7 May 2026 - LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities
5 May 2026 - LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking
30 Apr 2026 - LONDON MARKET MIDDAY: FTSE falls as blue chips weigh on market
29 Apr 2026 - Sensodyne maker Haleon warns of rising costs, but keeps 2026 outlook as US rebounds
29 Apr 2026 - WINNERS & LOSERS: Treatt agrees to takeover; Futura swing to loss
29 Apr 2026 - WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach
29 Apr 2026 - Haleon stands by full-year outlook as revenue edges higher
29 Apr 2026
Related News
LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities
(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:
LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
Haleon News
LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities
(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:
LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
LONDON MARKET MIDDAY: FTSE falls as blue chips weigh on market
(Alliance News) - Stock prices in London extended losses by midday Wednesday, as weakness among blue chips outweighed strength in smaller caps.
Sensodyne maker Haleon warns of rising costs, but keeps 2026 outlook as US rebounds
* Haleon warns of rising freight costs
WINNERS & LOSERS: Treatt agrees to takeover; Futura swing to loss
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.
WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.
Haleon stands by full-year outlook as revenue edges higher
(Alliance News) - Haleon PLC on Wednesday reported increased quarterly revenue and reiterated its growth forecasts for the year.
Follow the stocks
